From FiercePharma: GlaxosmithKline's Lamictal XR--an extended release version of its off-patent Lamictal--has been approved as an add-on therapy for patients 13 years and older with partial seizures. In a 19-week study, Lamictal significantly reduced frequency of seizures compared with the placebo. The drug will be available this summer, the company said in a statement. GSK... Continue Reading →
I’m learning to fly
I'm optimistic and feeling consistently healthier even after a whopping 35% cut in Lamictal in a two week time period. I'm down to 125 mg from a high of 400 mg. This song makes me think of the life ahead of me. Full of promise and hope but not completely without trepidation.
You must be logged in to post a comment.